Healthleap raises $38 million for its AI that flags patients needing closer review
| Source: TechCrunch | Original article
Healthleap secured $38M to expand its AI that flags hospital patients at risk, with an $8M seed round co-led by Sequoia Capital and First Round Capital and a $30M Series A led by Hummingbird Ventures.
Healthleap, a Nordic‑based AI startup, announced a $38 million financing round to expand its hospital‑focused platform that scans electronic health records and flags patients who may have undiagnosed conditions. The round combines an $8 million seed round co‑led by Sequoia Capital and First Round Capital with a $30 million Series A led by Hummingbird Ventures. The company, founded by siblings Jemima and Josiah Meyer, did not disclose a valuation.
Healthleap’s software plugs into a hospital’s EHR system and uses large language models to extract clinical signals that busy care teams might miss. More than 50 hospitals are already using the tool, including for delirium detection. A peer‑reviewed study has evaluated its malnutrition‑screening capability at one site, and a case study from Penn Medicine attributes $23.8 million in annualized impact to the program.
The funding underscores growing investor confidence in AI that augments clinical decision‑making rather than replaces clinicians. By surfacing hidden risk factors, the technology promises earlier interventions, improved patient outcomes and reduced downstream costs—issues that have drawn regulatory attention, as seen in recent debates over AI‑driven diagnostics and treatment recommendations.
What to watch next: Healthleap plans to broaden its condition‑specific modules and deepen integration with hospital workflows. Observers will be looking for additional peer‑reviewed evidence of clinical benefit, potential regulatory reviews of AI‑based screening tools, and whether the company can sustain adoption across larger health systems while navigating data‑privacy and safety standards.
Sources
Back to AIPULSEN